{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:25:35Z","timestamp":1761218735557,"version":"3.41.2"},"reference-count":99,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hepatitis B virus (HBV) is a globally prevalent pathogen that poses significant public health challenges. Active HBV replication can trigger immune responses that result in liver damage. Tuberculosis (TB), caused by <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (<jats:italic>Mtb<\/jats:italic>), remains one of the leading causes of death from a single infectious agent worldwide. Notably, in TB patients with HBV infection and, the incidence of adverse events is six times higher than in those with TB alone, and HBV infection increases the risk of latent TB. However, the relationship between HBV and TB have not been thoroughly investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To elucidate the relationship between HBV and TB, we performed an integrated bioinformatics analysis using expression profiling and RNA sequencing data from the GSE83148 and GSE126614 datasets. We identified differentially expressed genes (DEGs) associated with both diseases and analyzed shared biological pathways, key genes, transcriptional regulatory networks, and gene-disease associations. Furthermore, we predicted potential therapeutic agents targeting these shared molecular features.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 35 overlapping DEGs were identified for in-depth analysis. Functional enrichment revealed that these genes are involved in both immune-related pathways and cellular metabolic regulation, underscoring their potential role in the progression of HBV and TB. Protein\u2013protein interaction (PPI) network analysis highlighted four hub genes: CCL2, CD69, EGR2, and CCL20. Additionally, 35 transcription factors (TFs) were predicted to regulate these hub genes. Several candidate drugs, including etoposide, 8-azaguanine, menaquinone, emetine and N-acetyl-L-cysteine, were identified as potential therapeutic options. The DEGs were also significantly associated with other conditions such as pneumonia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study provides novel insights into the relationship between HBV and TB, offering potential targets for diagnosis and treatment. Our findings may contribute to the development of integrated strategies to manage HBV infection and TB more effectively.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1519216","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T05:21:19Z","timestamp":1749705679000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigation of the relationship between chronic hepatitis B and tuberculosis using bioinformatics and systems biology approaches"],"prefix":"10.3389","volume":"12","author":[{"given":"Jinyi","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyuan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengda","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41575-020-0296-6","article-title":"The evolution and clinical impact of hepatitis B virus genome diversity","volume":"17","author":"Revill","year":"2020","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.21037\/hbsn-2024-754","article-title":"2024 latest report on hepatitis B virus epidemiology in China: current status, changing trajectory, and challenges","volume":"14","author":"Yan","year":"2025","journal-title":"Hepatobiliary Surg Nutr"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1075916","DOI":"10.3389\/fimmu.2022.1075916","article-title":"Hepatitis B functional cure and immune response","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/liv.12749","article-title":"HBV and the immune response","volume":"35","author":"Ferrari","year":"2015","journal-title":"Liver Int"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S2352-4642(23)00004-4","article-title":"Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis","volume":"7","author":"Gunasekera","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e511","DOI":"10.1016\/S2468-2667(23)00097-X","article-title":"Global, regional, and national estimates of tuberculosis incidence and case detection among incarcerated individuals from 2000 to 2019: a systematic analysis","volume":"8","author":"Martinez","year":"2023","journal-title":"Lancet Public Health"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"170077","DOI":"10.1183\/16000617.0077-2017","article-title":"Tuberculosis and lung damage: from epidemiology to pathophysiology","volume":"27","author":"Ravimohan","year":"2018","journal-title":"Eur Respir Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12879-018-3192-8","article-title":"Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.amjmed.2023.10.031","article-title":"Screening practices and risk factors for co-infection with latent tuberculosis and hepatitis B virus in an integrated healthcare system\u2014California, 2008\u20132019","volume":"137","author":"Malden","year":"2024","journal-title":"Am J Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1440-1843.2007.01069.x","article-title":"Clinical characteristics of tuberculosis in patients with liver cirrhosis","volume":"12","author":"Cho","year":"2007","journal-title":"Respirology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e1001227","DOI":"10.1371\/journal.ppat.1001227","article-title":"Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection","volume":"6","author":"Peppa","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.gastro.2012.10.039","article-title":"Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice","volume":"144","author":"Li","year":"2013","journal-title":"Gastroenterology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00535-012-0596-x","article-title":"Sequential immunological analysis of HBV\/HCV co-infected patients during Peg-IFN\/RBV therapy","volume":"47","author":"Kondo","year":"2012","journal-title":"J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e1005667","DOI":"10.1371\/journal.ppat.1005667","article-title":"CD4 T cell-derived IFN-\u03b3 plays a minimal role in control of pulmonary Mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent lethal disease","volume":"12","author":"Sakai","year":"2016","journal-title":"PLoS Pathog"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.chom.2015.12.003","article-title":"Antigen export reduces antigen presentation and limits T cell control of tuberculosis","volume":"19","author":"Srivastava","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.chom.2018.06.004","article-title":"Mechanisms of tuberculosis immune evasion as challenges to TB vaccine design","volume":"24","author":"Ernst","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","article-title":"Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management","volume":"3","author":"Ramappa","year":"2013","journal-title":"J Clin Exp Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"D760","DOI":"10.1093\/nar\/gkl887","article-title":"NCBI GEO: mining tens of millions of expression profiles\u2014database and tools update","volume":"35","author":"Barrett","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1111\/liv.13427","article-title":"Predictive model for inflammation grades of chronic hepatitis B: large-scale analysis of clinical parameters and gene expressions","volume":"37","author":"Zhou","year":"2017","journal-title":"Liver Int"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"43446","DOI":"10.1038\/srep43446","article-title":"Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","article-title":"Grading and staging systems for inflammation and fibrosis in chronic liver diseases","volume":"47","author":"Goodman","year":"2007","journal-title":"J Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1038\/s41564-022-01236-3","article-title":"Author Correction: Histone acetylome-wide associations in immune cells from individuals with active Mycobacterium tuberculosis infection","volume":"7","author":"RCH","year":"2022","journal-title":"Nat Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s11427-013-4557-2","article-title":"Transcriptomics: advances and approaches","volume":"56","author":"Dong","year":"2013","journal-title":"Sci China Life Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2014update","volume":"41","author":"Barrett","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1471-2105-15-293","article-title":"jvenn: an interactive Venn diagram viewer","volume":"15","author":"Bardou","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/bib\/bbr049","article-title":"Gene set enrichment analysis: performance evaluation and usage guidelines","volume":"13","author":"Hung","year":"2012","journal-title":"Brief Bioinform"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/nar\/gkg034","article-title":"STRING: a database of predicted functional associations between proteins","volume":"31","author":"von Mering","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S1357-2725(97)00085-X","article-title":"Transcription factors: an overview","volume":"29","author":"Latchman","year":"1997","journal-title":"Int J Biochem Cell Biol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nprot.2015.052","article-title":"NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data","volume":"10","author":"Xia","year":"2015","journal-title":"Nat Protoc"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"D91","DOI":"10.1093\/nar\/gkh012","article-title":"JASPAR: an open-access database for eukaryotic transcription factor binding profiles","volume":"32","author":"Sandelin","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","article-title":"DSigDB: drug signatures database for gene set analysis","volume":"31","author":"Yoo","year":"2015","journal-title":"Bioinformatics"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1016\/j.ygeno.2020.06.001","article-title":"Detection of molecular signatures and pathways shared in inflammatory bowel disease and colorectal cancer: a bioinformatics and systems biology approach","volume":"112","author":"Al-Mustanjid","year":"2020","journal-title":"Genomics"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.bpg.2017.05.003","article-title":"Hepatitis B virus infection and the immune response: the big questions","volume":"31","author":"Boeijen","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"104649","DOI":"10.1016\/j.meegid.2020.104649","article-title":"Human gene expression profiling identifies key therapeutic targets in tuberculosis infection: a systematic network meta-analysis","volume":"87","author":"Alam","year":"2021","journal-title":"Infect Genet Evol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1016\/j.vaccine.2011.06.012","article-title":"Hepatitis B virus core particles displaying Mycobacterium tuberculosis antigen ESAT-6 enhance ESAT-6-specific immune responses","volume":"29","author":"Yin","year":"2011","journal-title":"Vaccine"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2217\/fvl.12.123","article-title":"HIV-1 and the immune response to TB","volume":"8","author":"Walker","year":"","journal-title":"Future Virol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/hep.510310129","article-title":"Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection","volume":"31","author":"Wong","year":"2000","journal-title":"Hepatology"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nm.3251","article-title":"Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells","volume":"19","author":"Rehermann","year":"2013","journal-title":"Nat Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e47648","DOI":"10.1371\/journal.pone.0047648","article-title":"Upregulation of the Tim-3\/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection","volume":"7","author":"Nebbia","year":"2012","journal-title":"PLoS One"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.immuni.2011.12.002","article-title":"Innate and adaptive interferons suppress IL-1\u03b1 and IL-1\u03b2 production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection","volume":"35","author":"Mayer-Barber","year":"2011","journal-title":"Immunity"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1126\/science.1233665","article-title":"Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses","volume":"339","author":"Teles","year":"2013","journal-title":"Science"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.4049\/jimmunol.1401088","article-title":"Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-\u03b3 for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages","volume":"193","author":"FW","year":"2014","journal-title":"J Immunol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"","journal-title":"Nature"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/gene.2010.51","article-title":"Human gene expression profiles of susceptibility and resistance in tuberculosis","volume":"12","author":"Maertzdorf","year":"2011","journal-title":"Genes Immun"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"635335","DOI":"10.3389\/fcimb.2021.635335","article-title":"Understanding metabolic regulation between host and pathogens: new opportunities for the development of improved therapeutic strategies against Mycobacterium tuberculosis infection","volume":"11","author":"Park","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1033314","DOI":"10.3389\/fimmu.2022.1033314","article-title":"What role for cellular metabolism in the control of hepatitis viruses?","volume":"13","author":"Diaz","year":"2022","journal-title":"Front Immunol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.4049\/jimmunol.1501612","article-title":"Cutting edge: Mycobacterium tuberculosis induces aerobic glycolysis in human alveolar macrophages that is required for control of intracellular bacillary replication","volume":"196","author":"Gleeson","year":"2016","journal-title":"J Immunol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"e1004265","DOI":"10.1371\/journal.ppat.1004265","article-title":"Pathogenicity of Mycobacterium tuberculosis is expressed by regulating metabolic thresholds of the host macrophage","volume":"10","author":"Mehrotra","year":"2014","journal-title":"PLoS Pathog"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1182\/blood-2012-03-419747","article-title":"Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells","volume":"120","author":"Everts","year":"2012","journal-title":"Blood"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"101147","DOI":"10.1016\/j.redox.2019.101147","article-title":"Human and murine macrophages exhibit differential metabolic responses to lipopolysaccharide\u2014a divergent role for glycolysis","volume":"22","author":"Vijayan","year":"2019","journal-title":"Redox Biol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1038\/s41467-018-04804-6","article-title":"Glycolytic metabolism is essential for CCR7 oligomerization and dendritic cell migration","volume":"9","author":"Guak","year":"2018","journal-title":"Nat Commun"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1053457","DOI":"10.3389\/fimmu.2022.1053457","article-title":"CCL2: an important cytokine in normal and pathological pregnancies: a review","volume":"13","author":"Lin","year":"2022","journal-title":"Front Immunol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1136\/gutjnl-2018-317601","article-title":"APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression","volume":"68","author":"Wang","year":"2019","journal-title":"Gut"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ccr.2012.07.023","article-title":"TGF-\u03b2-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma","volume":"22","author":"Yang","year":"2012","journal-title":"Cancer Cell"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"e8459","DOI":"10.1371\/journal.pone.0008459","article-title":"CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis","volume":"4","author":"Hasan","year":"2009","journal-title":"PLoS One"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/eji.201646837","article-title":"CD69: from activation marker to metabolic gatekeeper","volume":"47","author":"Cibri\u00e1n","year":"2017","journal-title":"Eur J Immunol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3343\/alm.2024.0178","article-title":"CD69 expression is negatively associated with T-cell immunity and predicts antiviral therapy response in chronic hepatitis B","volume":"45","author":"Gu","year":"2025","journal-title":"Ann Lab Med"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3389\/fmicb.2020.01901","article-title":"Decreased expression of CD69 on T cells in tuberculosis infection resisters","volume":"11","author":"Chen","year":"2020","journal-title":"Front Microbiol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"36242","DOI":"10.1074\/jbc.M401290200","article-title":"Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor","volume":"279","author":"Yoo","year":"2004","journal-title":"J Biol Chem"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00251-009-0377-8","article-title":"A regulatory polymorphism in interferon-gamma receptor 1 promoter is associated with the susceptibility to chronic hepatitis B virus infection","volume":"61","author":"Zhou","year":"2009","journal-title":"Immunogenetics"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/sj.gene.6364353","article-title":"IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan","volume":"8","author":"Salih","year":"2007","journal-title":"Genes Immun"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.micinf.2014.08.005","article-title":"Transcriptional regulation of CCL20 expression","volume":"16","author":"Zhao","year":"2014","journal-title":"Microbes Infect"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/hep.26916","article-title":"Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment","volume":"59","author":"Zhao","year":"2014","journal-title":"Hepatology"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-3083.2007.02040.x","article-title":"Expression and regulation of the CC-chemokine ligand 20 during human tuberculosis","volume":"67","author":"Lee","year":"2008","journal-title":"Scand J Immunol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/febs.13627","article-title":"NFKB1: a suppressor of inflammation, ageing and cancer","volume":"283","author":"Cartwright","year":"2016","journal-title":"FEBS J"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.bbadis.2007.08.001","article-title":"Inhibition of hepatitis B virus replication by MyD88 is mediated by nuclear factor-kappaB activation","volume":"1772","author":"Lin","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1093\/annonc\/mdu451","article-title":"Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma","volume":"25","author":"Zhang","year":"2014","journal-title":"Ann Oncol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1038\/onc.2017.48","article-title":"FOXC1: an emerging marker and therapeutic target for cancer","volume":"36","author":"Han","year":"2017","journal-title":"Oncogene"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jhep.2012.04.020","article-title":"Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma","volume":"57","author":"Xia","year":"2012","journal-title":"J Hepatol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cancers11020184","article-title":"The diverse consequences of FOXC1 deregulation in cancer","volume":"11","author":"Gilding","year":"2019","journal-title":"Cancers"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"695278","DOI":"10.3389\/fimmu.2021.695278","article-title":"Mesenchymal stem cells and tuberculosis: clinical challenges and opportunities","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"95","DOI":"10.17179\/excli2015-561","article-title":"Molecular mechanisms of etoposide","volume":"14","author":"Montecucco","year":"2015","journal-title":"EXCLI J"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2257.2005.00728.x","article-title":"Haemophagocytic syndrome associated with hepatitis-B virus infection responding to etoposide","volume":"27","author":"Aleem","year":"2005","journal-title":"Clin Lab Haematol"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10495-011-0597-x","article-title":"Trichostatin A sensitizes HBx-expressing liver cancer cells to etoposide treatment","volume":"16","author":"Zhang","year":"2011","journal-title":"Apoptosis"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12879-020-05016-4","article-title":"Successful treatment of mycobacterial infection associated hemophagocytic lymphohistiocytosis with etoposide and anti-tuberculous therapy: a case report","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Infect Dis"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.intimp.2018.12.020","article-title":"Direct potentiation of NK cell cytotoxicity by 8-azaguanine with potential antineoplastic activity","volume":"67","author":"Kim","year":"","journal-title":"Int Immunopharmacol"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"e02236-17","DOI":"10.1128\/aac.02236-17","article-title":"Compounds with potential activity against Mycobacterium tuberculosis","volume":"62","author":"Sao Emani","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.numecd.2008.10.004","article-title":"A high menaquinone intake reduces the incidence of coronary heart disease","volume":"19","author":"Gast","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"112859","DOI":"10.1016\/j.ejmech.2020.112859","article-title":"Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates","volume":"209","author":"RCB","year":"2021","journal-title":"Eur J Med Chem"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1021\/acschembio.8b00402","article-title":"Mycobacterial MenJ: an oxidoreductase involved in menaquinone biosynthesis","volume":"13","author":"Upadhyay","year":"2018","journal-title":"ACS Chem Biol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.nut.2018.08.016","article-title":"Vitamin K2 supplementation blocks the beneficial effects of IFN-\u03b1-2b administered on the early stages of liver cancer development in rats","volume":"59","author":"Vera","year":"2019","journal-title":"Nutrition"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1001\/jama.292.3.358","article-title":"Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver","volume":"292","author":"Habu","year":"2004","journal-title":"JAMA"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2174\/1874848101104010008","article-title":"Biological activities of emetine","volume":"4","author":"Akinboye","year":"","journal-title":"Open Nat Prod J"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2147\/DDDT.S299120","article-title":"Progress of plant medicine derived extracts and alkaloids on modulating viral infections and inflammation","volume":"15","author":"Ti","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.4049\/jimmunol.160.5.2408","article-title":"Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects","volume":"160","author":"Silver","year":"1998","journal-title":"J Immunol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0166-3542(95)00977-9","article-title":"Anti-hepatitis B virus activity of N-acetyl-l-cysteine (NAC): new aspects of a well-established drug","volume":"32","author":"Weiss","year":"1996","journal-title":"Antivir Res"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"724224","DOI":"10.3389\/fmed.2021.724224","article-title":"Retrospective analysis of the clinical efficacy of N-acetylcysteine in the treatment of hepatitis B virus related acute-on-chronic liver failure","volume":"8","author":"Wang","year":"2021","journal-title":"Front Med"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12866-016-0872-7","article-title":"N-acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functions","volume":"16","author":"Amaral","year":"2016","journal-title":"BMC Microbiol"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1574-695X.2007.00256.x","article-title":"Mycobacterium tuberculosis H37Rv induces monocytic release of in terleukin-6 via activation of mitogen-activated protein kinases: inhibition by N-acetyl-l-cysteine","volume":"50","author":"Natarajan","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrclinonc.2016.96","article-title":"Combine and conquer: challenges for targeted therapy combinations in early phase trials","volume":"14","author":"Lopez","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41389-024-00510-9","article-title":"Designing patient-oriented combination therapies for acute myeloid leukemia based on efficacy\/toxicity integration and bipartite network modeling","volume":"13","author":"Mirzaie","year":"2024","journal-title":"Oncogenesis"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nri3447","article-title":"The good, the bad and the ugly\u2014TFH cells in human health and disease","volume":"13","author":"Tangye","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/jlb.63.1.108","article-title":"Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model","volume":"63","author":"Ajuebor","year":"1998","journal-title":"J Leukoc Biol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1519216\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T05:21:22Z","timestamp":1749705682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1519216\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":99,"alternative-id":["10.3389\/fmed.2025.1519216"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1519216","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"article-number":"1519216"}}